Fundz

Calluna Pharma Launches €75 Million Series A Financing

PRIVATEJan 23, 2024

Amount Raised

€75 Million

Round Type

Series A

NorwayBiotechnologyHealth CareTherapeuticsPharmaceutical

Investors

InvestinorP53SarsiaForbion

Description

Calluna Pharma Inc. has raised €75 million in a Series A financing round, backed by Oxitope and Arxx’s existing lead investors: Forbion, Sarsia, p53, and Investinor. The new company will combine expertise in the field of innate immunity with a pipeline of selective antibodies that target inflammatory and fibrotic indications.

Quick answer

Calluna Pharma raised €75 Million in a Series A round, dated January 23, 2024. Investors: Investinor, P53, Sarsia and Forbion. Calluna Pharma is based in Norway.

How much did Calluna Pharma raise?
Calluna Pharma raised €75 Million in a Series A round on January 23, 2024.
Who invested in Calluna Pharma?
Investinor, P53, Sarsia and Forbion are named as investors in this round.
What does Calluna Pharma do?
Calluna Pharma Inc. is a clinical company established through the merger of Oxitope Pharma and Arxx Therapeutics, aiming to develop therapies for inflammatory and fibrotic diseases by targeting innate immune system..
Where is Calluna Pharma based and how big is it?
Calluna Pharma is based in Norway.
Who are the decision-makers at Calluna Pharma?
Fundz holds 1 contact at Calluna Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Calluna Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Azora Therapeutics, Inc. (DE) raised $288K (Seed) on March 6, 2024.
  • Parabilis Medicines raised $145M (Series E) on March 1, 2024.
  • Crinetics Pharmaceuticals raised $350M on March 1, 2024.
  • vTv Therapeutics Inc. raised $51M on February 27, 2024.
  • XORTX Therapeutics raised $2.5M (Seed) on February 19, 2024.
  • Biofrontera raised $8M on February 19, 2024.

Who to call at Calluna Pharma, and when

A new round usually means Calluna Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Calluna Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Calluna Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Calluna Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Calluna Pharma

Location

Norway

About

Calluna Pharma Inc. is a clinical company established through the merger of Oxitope Pharma and Arxx Therapeutics, aiming to develop therapies for inflammatory and fibrotic diseases by targeting innate immune system components.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Calluna Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Calluna Pharma's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Calluna Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.